淋巴瘤 18F-FDG PET/CT及PET/MR显像临床应用指南（2021版）

2021-03-28 中华医学会核医学分会中华核医学与分子影像杂志.2021.41(3):161-169.

本指南在《淋巴瘤18 F⁃FDG PET/ CT 显像临床应用指南(2016 版)》的基础上，结合近期的文献证据和专家共识，对推荐内容、推荐水平以及证据水平进行了相应修改，增加了1

中文标题：

发布机构：

中华医学会核医学分会

发布日期：

2021-03-28

简要介绍：

本指南在《淋巴瘤18 F⁃FDG PET/ CT 显像临床应用指南(2016 版)》的基础上，结合近期的文献证据和专家共识，对推荐内容、推荐水平以及证据水平进行了相应修改，增加了18 F⁃FDG PET/ CT 指导放疗策略、淋巴瘤免疫治疗疗效评价､18 F⁃FDG PET/ MR 应用、伯基特淋巴瘤(Burkitt lymphoma, BL)和胃黏膜相关淋巴组织( mucosa⁃associated lymphoid tissue,MALT)淋巴瘤的分期及评估、淋巴瘤18 F⁃FDG PET/CT 及PET/ MR 显像报告要点等。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=ed4061c0020899a2, title=淋巴瘤 18F-FDG PET/CT及PET/MR显像临床应用指南（2021版）, enTitle=, guiderFrom=中华核医学与分子影像杂志.2021.41(3):161-169., authorId=0, author=, summary=本指南在《淋巴瘤18 F⁃FDG PET/ CT 显像临床应用指南(2016 版)》的基础上，结合近期的文献证据和专家共识，对推荐内容、推荐水平以及证据水平进行了相应修改，增加了1, cover=https://img.medsci.cn/2021426/1619449181573_2020535.jpg, journalId=0, articlesId=null, associationId=205, associationName=中华医学会核医学分会, associationIntro=中华医学会核医学分会是中华医学会所属许多专科分会之一，是中华医学会领导下的非独立法人学术分支机构。1980年5月在石家庄召开了第一次全国核医学学术会议，在这次会议上成立了”中华医学会、中国核学会核医学学会”，核医学会受两个学会的双重领导。这次大会是在王世真院士的倡导下召开的,对推动我国核医学的发展起了重要作用。中华医学会核医学分会第一至第九届委员会主任委员先后由王世真院士、周前、林祥通、刘秀杰、屈婉莹、陈盛祖、匡安仁、田嘉禾和黄钢教授担任。, copyright=0, guiderPublishedTime=Sun Mar 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p><span style="color: black;">本指南在《淋巴瘤</span>18 F⁃FDG PET/ CT <span style="color: black;">显像临床应用指南</span>(2016 <span style="color: black;">版</span>)<span style="color: black;">》的基础上，结合近期的文献证据和专家共识，对推荐内容、推荐水平以及证据水平进行了相应修改，增加了</span>18 F⁃FDG PET/ CT <span style="color: black;">指导放疗策略、淋巴瘤免疫治疗疗效评价､</span>18 F⁃FDG PET/ MR <span style="color: black;">应用、伯基特淋巴瘤</span>(Burkitt lymphoma, BL)<span style="color: black;">和胃黏膜相关淋巴组织</span>( mucosa⁃associated lymphoid tissue,MALT)<span style="color: black;">淋巴瘤的分期及评估、淋巴瘤</span>18 F⁃FDG PET/CT <span style="color: black;">及</span>PET/ MR <span style="color: black;">显像报告要点等。</span></p> </div> </div> </div>, tagList=[TagDto(tagId=412, tagName=淋巴瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=412, guiderKeyword=淋巴瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10615, appHits=271, showAppHits=0, pcHits=1234, showPcHits=10344, likes=1, shares=28, comments=23, approvalStatus=1, publishedTime=Mon Apr 26 23:27:36 CST 2021, publishedTimeString=2021-03-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Apr 26 23:02:04 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 19:34:52 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=MR显像临床应用指南(2021版) .pdf)])

MR显像临床应用指南(2021版) .pdf

下载请点击：

评论区 (19)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2185802, encodeId=7eaa218580229, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIzQApmJbtqticm0fATqOtfMeB18sc5lJpicxD0ZpcXA6rNTmFicwRvzeyvt9icktVUfS8549VxznkzoA/132, createdBy=f3fd5289385, createdName=CYX0727, createdTime=Sun Feb 04 12:23:51 CST 2024, time=2024-02-04, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1218760, encodeId=9c7f1218e60f7, content=少见的PET/MR指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c482783002, createdName=ccmu_mengzt, createdTime=Wed May 11 15:34:24 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206757, encodeId=32941206e575d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=lexi Liao, createdTime=Tue Mar 29 00:39:06 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202280, encodeId=189c12022807b, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e615597068, createdName=ms7000001910826648, createdTime=Sun Mar 13 18:20:28 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083485, encodeId=2c431083485d2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b652296196, createdName=121f83cam29暂无昵称, createdTime=Thu Dec 23 10:22:43 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
2024-02-04 CYX0727 来自云南省

学习了

11 0
[GetPortalCommentsPageByObjectIdResponse(id=2185802, encodeId=7eaa218580229, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIzQApmJbtqticm0fATqOtfMeB18sc5lJpicxD0ZpcXA6rNTmFicwRvzeyvt9icktVUfS8549VxznkzoA/132, createdBy=f3fd5289385, createdName=CYX0727, createdTime=Sun Feb 04 12:23:51 CST 2024, time=2024-02-04, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1218760, encodeId=9c7f1218e60f7, content=少见的PET/MR指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c482783002, createdName=ccmu_mengzt, createdTime=Wed May 11 15:34:24 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206757, encodeId=32941206e575d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=lexi Liao, createdTime=Tue Mar 29 00:39:06 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202280, encodeId=189c12022807b, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e615597068, createdName=ms7000001910826648, createdTime=Sun Mar 13 18:20:28 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083485, encodeId=2c431083485d2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b652296196, createdName=121f83cam29暂无昵称, createdTime=Thu Dec 23 10:22:43 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
2022-05-11 ccmu_mengzt

少见的PET/MR指南

36 0
[GetPortalCommentsPageByObjectIdResponse(id=2185802, encodeId=7eaa218580229, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIzQApmJbtqticm0fATqOtfMeB18sc5lJpicxD0ZpcXA6rNTmFicwRvzeyvt9icktVUfS8549VxznkzoA/132, createdBy=f3fd5289385, createdName=CYX0727, createdTime=Sun Feb 04 12:23:51 CST 2024, time=2024-02-04, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1218760, encodeId=9c7f1218e60f7, content=少见的PET/MR指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c482783002, createdName=ccmu_mengzt, createdTime=Wed May 11 15:34:24 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206757, encodeId=32941206e575d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=lexi Liao, createdTime=Tue Mar 29 00:39:06 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202280, encodeId=189c12022807b, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e615597068, createdName=ms7000001910826648, createdTime=Sun Mar 13 18:20:28 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083485, encodeId=2c431083485d2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b652296196, createdName=121f83cam29暂无昵称, createdTime=Thu Dec 23 10:22:43 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
2022-03-29 lexi Liao

学习

47 0
[GetPortalCommentsPageByObjectIdResponse(id=2185802, encodeId=7eaa218580229, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIzQApmJbtqticm0fATqOtfMeB18sc5lJpicxD0ZpcXA6rNTmFicwRvzeyvt9icktVUfS8549VxznkzoA/132, createdBy=f3fd5289385, createdName=CYX0727, createdTime=Sun Feb 04 12:23:51 CST 2024, time=2024-02-04, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1218760, encodeId=9c7f1218e60f7, content=少见的PET/MR指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c482783002, createdName=ccmu_mengzt, createdTime=Wed May 11 15:34:24 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206757, encodeId=32941206e575d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=lexi Liao, createdTime=Tue Mar 29 00:39:06 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202280, encodeId=189c12022807b, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e615597068, createdName=ms7000001910826648, createdTime=Sun Mar 13 18:20:28 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083485, encodeId=2c431083485d2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b652296196, createdName=121f83cam29暂无昵称, createdTime=Thu Dec 23 10:22:43 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
2022-03-13 ms7000001910826648

已学习

46 0
[GetPortalCommentsPageByObjectIdResponse(id=2185802, encodeId=7eaa218580229, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIzQApmJbtqticm0fATqOtfMeB18sc5lJpicxD0ZpcXA6rNTmFicwRvzeyvt9icktVUfS8549VxznkzoA/132, createdBy=f3fd5289385, createdName=CYX0727, createdTime=Sun Feb 04 12:23:51 CST 2024, time=2024-02-04, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1218760, encodeId=9c7f1218e60f7, content=少见的PET/MR指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c482783002, createdName=ccmu_mengzt, createdTime=Wed May 11 15:34:24 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206757, encodeId=32941206e575d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=lexi Liao, createdTime=Tue Mar 29 00:39:06 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202280, encodeId=189c12022807b, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e615597068, createdName=ms7000001910826648, createdTime=Sun Mar 13 18:20:28 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083485, encodeId=2c431083485d2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b652296196, createdName=121f83cam29暂无昵称, createdTime=Thu Dec 23 10:22:43 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
2021-12-23 121f83cam29暂无昵称

学习

59 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科指南

淋巴瘤 18F-FDG PET/CT及PET/MR显像临床应用指南（2021版）

相关指南

拓展阅读

科室

工具

服务